China Universal Asset Management Co., Ltd.

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1906594 SHANGHAI, F4

Position in LENZ

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$28,343

-$22,466 QoQ

Shares Held

4,990

-10.1% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#100

of 143 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

China Universal Asset Management Co., Ltd. holds $180,189,557 across 240 Biotechnology names. LENZ ranks #221 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	48,265	$23,974,673
2	REGN	Regeneron Pharmaceuticals, Inc.	19,498	$12,157,782
3	ALNY	Alnylam Pharmaceuticals, Inc.	25,269	$7,606,727
4	RPRX	Royalty Pharma plc	120,547	$6,759,070
5	RVMD	Revolution Medicines, Inc.	33,835	$6,336,618
6	IONS	Ionis Pharmaceuticals Inc	76,302	$6,049,985
7	MRNA	Moderna, Inc.	63,149	$4,422,324
8	ARGX	Argenx SE	4,642	$4,306,708

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$28,343	4,990	-10.1%	Shares	Sole	2026-07-24
2026-03-31	$50,809	5,553	+8.9%	Shares	Sole	2026-04-28
2025-12-31	$81,584	5,099	-36.3%	Shares	Sole	2026-01-29
2025-09-30	$372,593	7,999	+41.5%	Shares	Sole	2025-11-10
2025-06-30	$165,689	5,653	+2.5%	Shares	Sole	2025-08-28
2025-03-31	$141,816	5,516	-5.4%	Shares	Sole	2025-04-30
2024-12-31	$168,340	5,831	—	Shares	Sole	2025-01-24
2023-09-30 GRPH	—	1,484	+95.0%	Shares	Sole	2024-05-22
2023-06-30 GRPH	—	761	-3.4%	Shares	Sole	2024-05-22
2023-03-31 GRPH	—	788	+33.3%	Shares	Sole	2024-05-22
2022-12-31 GRPH	—	591	+8.2%	Shares	Sole	2024-05-22
2022-09-30 GRPH	—	546	—	Shares	Sole	2022-10-21
No filing history on record for this holder in this stock.